Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine in women the risk/benefit profile and
non-inferiority of a topical 5% Minoxidil foam formulation applied once daily for the
treatment of androgenetic alopecia in comparison to 2% MTS used twice daily, using objective
and subjective efficacy measures and safety assessments for a study period of 24 weeks.